Fennec Pharmaceuticals Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 1 | -$0.07 | -$0.05 | -$0.06 |
Q2 2024 | 1 | -$0.03 | -$0.02 | -$0.03 |
Q3 2024 | 1 | -$0.11 | -$0.07 | -$0.09 |
Q4 2024 | 2 | -$0.16 | -$0.05 | -$0.10 |
Q1 2025 | 2 | -$0.11 | -$0.08 | -$0.10 |
Q2 2025 | 1 | -$0.07 | -$0.05 | -$0.06 |
Q3 2025 | 1 | $0.14 | $0.21 | $0.17 |
Q4 2025 | 1 | $0.04 | $0.06 | $0.05 |
Q1 2026 | 1 | $0.04 | $0.07 | $0.06 |
Q2 2026 | 1 | $0.05 | $0.07 | $0.06 |
Q3 2026 | 1 | $0.05 | $0.08 | $0.06 |
Q4 2026 | 1 | $0.05 | $0.08 | $0.06 |
Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
Q4 2027 | 0 | $0.00 | $0.00 | $0.00 |
Fennec Pharmaceuticals Inc. Earnings Date And Information
Fennec Pharmaceuticals Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.21 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.08. The company had revenue of 6.97 M for the quarter and had revenue of 21.25 M for the year. Fennec Pharmaceuticals Inc. has generated $-1 earnings per share over the last year ($-0.6 diluted earnings per share) and currently has a price-to-earnings ratio of -120.74. Fennec Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based on prior year's report dates.
Fennec Pharmaceuticals Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/08/2024 | Q3 2024 | -$0.21 | $8.99 M | $6.97 M | ||
08/13/2024 | Q2 2024 | $0.06 | -$0.20 | -0.26 | $11.05 M | $7.26 M |
05/14/2024 | Q1 2024 | $0.26 | $0.47 | 0.21 | $25.26 M | |
03/29/2024 | Q4 2023 | -$0.10 | $10.00 M | |||
11/09/2023 | Q3 2023 | -$0.07 | $5.33 M | $6.52 M | ||
08/07/2023 | Q2 2023 | -$0.21 | $3.72 M | $3.33 M | ||
05/12/2023 | Q1 2023 | -$0.29 | $1.68 M | |||
03/29/2023 | Q4 2022 | -$0.30 | $1.54 M | |||
11/14/2022 | Q3 2022 | -$0.31 | $0 | |||
08/12/2022 | Q2 2022 | -$0.10 | -$0.19 | -0.09 | $0 | |
05/12/2022 | Q1 2022 | -$0.13 | -$0.15 | -0.02 | $0 | |
02/28/2022 | Q4 2021 | $3.52 | -$0.17 | -3.69 | $0 | |
11/10/2021 | Q3 2021 | -$0.18 | -$0.16 | 0.02 | $0 | |
08/10/2021 | Q2 2021 | -$0.19 | -$0.15 | 0.04 | $0 | |
05/13/2021 | Q1 2021 | -$0.12 | -$0.18 | -0.06 | $0 | |
03/30/2021 | Q4 2020 | -$0.14 | $170,000 | |||
11/16/2020 | Q3 2020 | -$0.18 | -$0.24 | -0.06 | $0 | |
08/05/2020 | Q2 2020 | -$0.19 | -$0.21 | -0.02 | $0 | |
05/14/2020 | Q1 2020 | -$0.19 | -$0.19 | 0 | $0 | |
02/14/2020 | Q4 2019 | -$0.13 | -$0.18 | -0.05 | $0 |
Fennec Pharmaceuticals Inc. Earnings: Frequently Asked Questions
-
When is Fennec Pharmaceuticals Inc.'s earnings date?
Fennec Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 20th, 2025 based off last year's report dates.
-
How can I listen to Fennec Pharmaceuticals Inc.'s earnings conference call?
The conference call for Fennec Pharmaceuticals Inc.'s latest earnings report can be listened to online.
-
How can I read Fennec Pharmaceuticals Inc.'s conference call transcript?
The conference call transcript for Fennec Pharmaceuticals Inc.'s latest earnings report can be read online.
-
How much revenue does Fennec Pharmaceuticals Inc. generate each year?
Fennec Pharmaceuticals Inc. (:FENC) has a recorded annual revenue of $21.25 M.
-
How much profit does Fennec Pharmaceuticals Inc. generate each year?
Fennec Pharmaceuticals Inc. (:FENC) has a recorded net income of $21.25 M. Fennec Pharmaceuticals Inc. has generated $-0.6 earnings per share over the last four quarters.
-
What is Fennec Pharmaceuticals Inc.'s price-to-earnings ratio?
Fennec Pharmaceuticals Inc. (:FENC) has a price-to-earnings ratio of -120.74 and price/earnings-to-growth ratio is 0.86.